-
¹ØÓÚwelcome-ÇòËÙÌåÓý
-
-
ÐÂÎŶ¯Ì¬
-
-
-
Éç»áÔðÈÎ
-
Ͷ×ÊÕß¹Øϵ
²úÆ·ÖÐÐÄ
ÁªÏµwelcome-ÇòËÙÌåÓý
ÏúÊÛרÓãº
µØÖ·£º±±¾©Êк£µíÇøÎ÷Ó׿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã
Y-shape PEG Amine
²úÆ·´úºÅ£º
Y-PEG-NH2
²úÆ·´¿¶È£º
¡Ý 95%
°ü×°¹æ¸ñ£º
1g, 10g, 100gµÈ£¨ÌØÊâ°ü×°ÐèÊÕÈ¡·Ö×°Óöȣ©
·Ö×ÓÁ¿£º
40000 DaµÈ
¹Ø¼ü´Ê£º
ËùÊô·ÖÀࣺ
¿ÆÑпͻ§Ó×ÅúÁ¿Ò»¼ü²É¹ºµØÖ·£¨Ó×ÓÚ5¿Ë£©
- ²úÆ·ÃèÊö
- ²Î¿¼Îļþ
-
¡¡¡¡ÓµÓÐYÐÍ·ÖÖ§µÄY-¾ÛÒÒ¶þ´¼°±»ù»¯ºÏÎïÄܹ»Óëµ×ÎïÐγÉõ£°·¡¢ëåÍé»ò¶þ¼¶°·µÈÓµÓв»±ä½á¹¹µÄ»¯Ñ§¼ü¡£YÐÍ°·¾ÛÒÒ¶þ´¼½á¹¹Öеݱ»ù»¯ôÇ»ù¸üÒ×ÓÚÓë±ûÏ©õ£»¯ÊÔ¼Á½øÐз´Ó³£¬Ëü»¹ÈÝÒײúÉú»¹Ô°±»ù»¯·´Ó³¡£welcome-ÇòËÙÌåÓý²úÆ·Y·ÖÖ§ÑÜÉúÎïÊÇ×ÔÖ÷Ñз¢µÄYÐͽṹ£¬ÓÉÓÚÓµÓйÖÒìµÄ¿Õ¼ä½á¹¹Ê¹ËûÃDZÈÏßÐÔ¾ÛÒÒ¶þ´¼ÑÜÉúÎï¸üÓµÓÐÑ¡ÔñÐÔ¡£
²úÆ·±àÂë
²úÆ·´úºÅ
A0010F
Y-NH2-40K
A0044
Y-NH2HCl-40K
¡¡¡¡welcome-ÇòËÙÌåÓý¿Æ¼¼Ìṩ·Ö×°·þÎñ£¬±ØÒªÊÕÈ¡·Ö×°Óöȣ¬ÈôÊÇÄú±ØÒª·ÖװΪÆäËû¹æ¸ñÇëÓëÎÒÃÇÁªÏµ¡£
¡¡¡¡welcome-ÇòËÙÌåÓý¿Æ¼¼Í¬Ê±ÌṩÆäËû·Ö×ÓÁ¿µÄYÐÍÑÜÉúÎï²úÆ·£¬ÈçÄã±ØÒªÇëÓëÎÒ˾sales@jenkem.comÁªÏµ¡£
¡¡¡¡welcome-ÇòËÙÌåÓý¿Æ¼¼Ìṩ´óÅúÁ¿³ö²ú²úÆ·¼°GMP¼¶±ð²úÆ·£¬ÈçÐ豨¼ÛÇëÓëÎÒÃÇÁªÏµ¡£
-
¡¡¡¡References:
¡¡¡¡1. Amoozgar, Z., et al., Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model, Biomacromolecules. 2014, 15(11):4187-94.
¡¡¡¡2. Hoehlig, K., et al., A novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsis. Mol Ther, 2013, 21(12): p. 2236-46.
²úƷѯ¼Û
welcome-ÇòËÙÌåÓý
EN
·þÎñÈÈÏߣº+86-010-82156767
ÏúÊÛרÓãº+86-010-62983737
²úÆ·Õ÷ѯ£ºsales@jenkem.com
µØÖ·£º±±¾©Êк£µíÇøÎ÷Ó׿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã
΢ÐŹ«¼ÒºÅ
΢ÐŹ«¼ÒºÅ